Allogeneic Mesenchymal Bone Marrow Cells
AssetCell therapyAlso aMBMC
Allogeneic bone marrow-derived mesenchymal stem cells promoting tissue repair and immunomodulation.
- Stage
- Phase 2
- Modality
- Cell therapy
- Target
- Inflammation
- Indications
- 1
- Trials
- 128
- Developers
- 1
Indications
1Non ischemic heart failure
Phase 2COMPLETEDNCT02467387clinicaltrials.gov7 Oct 2026
- Targets and what it contains2
- Owner and partners1
- Trials128
- Evidence for its targets2
- Competitors3
- Aging relevance2
- Signals6
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 2 sources